1. Collaboration of MYC and RUNX2 in lymphoma simulates T‐cell receptor signaling and attenuates p53 pathway activity. Issue 10 (30th June 2019) Authors: Hay, Jodie; Gilroy, Kathryn; Huser, Camille; Kilbey, Anna; Mcdonald, Alma; MacCallum, Amanda; Holroyd, Ailsa; Cameron, Ewan; Neil, James C. Journal: Journal of cellular biochemistry Issue: Volume 120:Issue 10(2019) Page Start: 18332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CXCR2 inhibition enables NASH-HCC immunotherapy. Issue 10 (27th April 2022) Authors: Leslie, Jack; Mackey, John B G; Jamieson, Thomas; Ramon-Gil, Erik; Drake, Thomas M; Fercoq, Frédéric; Clark, William; Gilroy, Kathryn; Hedley, Ann; Nixon, Colin; Luli, Saimir; Laszczewska, Maja; Pinyol, Roser; Esteban-Fabró, Roger; Willoughby, Catherine E; Haber, Philipp K; Andreu-Oller, Carmen; ... Journal: Gut Issue: Volume 71:Issue 10(2022) Page Start: 2093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RUNX‐mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins. Issue 3 (20th November 2017) Authors: Anderson, Gail; Mackay, Nancy; Gilroy, Kathryn; Hay, Jodie; Borland, Gillian; McDonald, Alma; Bell, Margaret; Hassanudin, Siti Ayuni; Cameron, Ewan; Neil, James C.; Kilbey, Anna Journal: Journal of cellular biochemistry Issue: Volume 119:Issue 3(2018) Page Start: 2750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗